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Abstract
Background: As a standard reference to evaluate male factor infertility, the majority of fertility laboratories use
the 4th or 5th Editions of the World Health Organization’s semen analysis guidelines. Following the release of the 5th
Edition, debate over its legitimacy has resulted in some laboratories using the 4th and others the 5th Edition. DNA
integrity tests have been shown to be a valuable adjunct to semen analysis and have subsequently been adopted
by many fertility laboratories. This study explored the prevalence of samples with high DNA fragmentation levels
according to semen analysis categories using both the 4th and the 5th Edition reference ranges.
Materials and Methods: The study included 905 consecutive semen samples from 863 infertile couples
attending a fertility clinic. A semen analysis was conducted according to both the 4th and 5th Edition guidelines
published by the World Health Organization. DNA damage was assessed using the Halosperm G2 test kit and
expressed as a percentage DNA fragmentation level.
Results: Alongside both the World Health Organization 4th and 5th Edition semen analysis criteria abnormal
DNA fragmentation levels were more common in abnormal semen samples however elevated DNA fragmentation
levels were also found in normal semen samples using the same criteria. Of the samples that were graded as
normozoospermic according to the 5th Edition guidelines 16% were deemed to have elevated DNA fragmentation
levels compared to 11.7% graded by the 4th Edition guidelines. The number of normozoospermic samples, graded
according to the 5th Edition guidelines was significantly higher (n=697) than when the same samples were graded
according to 4th Edition guidelines (n=385) (p=0.001). A significant proportion of samples with an abnormal DNA
fragmentation level corresponding to the World Health Organisation 4th and 5th Edition criteria were evident in
normozoospermic (p <0.05), normoteratozoospermic (p=<0.005) and normoasthenozoospermic (p<0.05) samples.
Conclusion: Our findings indicate that abnormal DNA fragmentation levels are proportionate to the World Health
Organisation semen analysis criteria with fragmentation levels increasing according to the increasing number of
semen analysis abnormalities. In some cases however, abnormal fragmentation levels were recorded when semen
analysis was normal and normal fragmentation levels were recorded where the semen analysis was considered
abnormal.

Keywords: DNA fragmentation; Halosperm; Semen analysis; WHO
4th Edition; WHO 5th Edition; Sperm; DNA damage
Introduction
Traditionally, male infertility is diagnosed using World Health
Organization (WHO) standard parameters which are published in a
laboratory manual providing guidelines to laboratories for processing
human semen and cut-off values to determine normality or abnormality
[1]. Since publication of the first manual in 1980 there have been a
number of updates released with the latest two editions being the 4th
Edition in 1999 and the 5th Edition in 2010 [2]. Substantial changes
between the two editions have resulted in the same patient being
diagnosed (under the 5th Edition guidelines) with a normal semen
analysis when they would have been diagnosed with an abnormal
semen analysis had the laboratory used the previous version cut-off
values. However, the application and reference values presented in the
4th Edition resulted from vague reference populations and therefore
lacked transparency, resulting in little consensus around the accuracy
of these values [3,4]. Furthermore this was acknowledged by the WHO
[2,5]. Although the 5th Edition has included clearly defined reference
ranges, concerns have been raised over the studies that generated these
values [2] and so debate has ensued over its legitimacy leaving no
definitive agreement between laboratories as to which edition should
be used [6].
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While semen analysis is regarded as a key tool to evaluate male
infertility [4] in spite of which reference values are used [7] it does
not consider sperm DNA integrity. DNA fragmentation testing whilst
considered useful, has not yet been universally accepted due to a lack of
standardization of tests and protocols [8].
Since about 15% of infertile men undergoing a semen analysis will
have semen within normal parameters [9,10], there has been a focus
on sperm DNA fragmentation and its association with infertility.
Elevated levels of DNA fragmentation have been linked with infertile
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men [10-14], poor fertilization rates [15,16], specific semen defects
[17], miscarriage and poor artificial reproductive technology results
[18]. Furthermore, infertile men have been shown to have substantially
higher levels of DNA fragmentation than fertile men [13] and hence
DNA fragmentation testing has been proposed as a valuable adjunct
to routine semen analysis when considering the fertility potential of a
man [16].
Although DNA fragmentation testing can be conducted in a
number of ways, the Halosperm assay has been described as a ‘cheap
and convenient’ test [18] that has a relatively short and simple protocol
with correlations having been observed with some of the most
commonly recognised tests [11,19-21]. The aim of this study was to
formally investigate the clinical significance of the Halosperm test and
assess its relationship to the two most recent WHO semen analysis
guidelines.

Materials and Methods
We studied 905 consecutive semen samples from 863 men who
underwent semen analysis and DNA fragmentation testing using
the Halosperm assay as part of their fertility treatment. The study
was approved by the Edith Cowan University Human Research
Ethics committee and the Joondalup Health Campus Human Ethics
Committee.

Semen analysis
Men were instructed to have 2 to 5 days sexual abstinence before
producing a semen sample for analysis. Semen samples were collected
by masturbation into a clean 60 ml wide-mouthed universal container
and processed within 1 hour of ejaculation and liquefaction. Semen
analysis was performed according to the WHO 4th Edition guidelines
[22] for volume, concentration, motility and morphology. Semen
samples were then classified according to both WHO 4th and 5th
Edition criteria [1] as shown in Table 1.
Following semen analysis, DNA fragmentation analysis was carried
out using the Halosperm G2 test kit (Halotech DNA SL). Details of
this procedure have been described elsewhere [23] but briefly, semen
samples were mixed with a liquefied agarose gel and placed onto
a pre-coated slide. The slides were refrigerated for 5 minutes before
being treated with a denaturing agent, followed by a lysis solution and
finally staining solutions. The criteria to determine fragmented and
non-fragmented DNA was followed according to the manufacturer’s
instructions. In essence spermatozoa with a large or medium sized
halo depict unfragmented DNA whilst those with either a small halo
or without a halo and those with a weak or irregular stained core depict
fragmented DNA. The DNA Fragmentation Levels (DFL) for each
sample was assessed by counting a minimum of 300 sperm under the
x100 objective of the microscope. The numbers of sperm judged to have
fragmented DNA were expressed as a percentage of the total number.
Samples with a reading of >30% were deemed abnormal.

Statistical Analysis
Pearson correlations and analysis by ANOVA were performed to
study the relationship between sperm DNA fragmentation and semen
analysis results with post-hoc testing by Tukey’s HSD and proportions
compared by a Chi-squared test. The minimum level of significance
was set at P <0.05. Microsoft Excel and StatistiXL (Nedlands, Western
Australia) statistical packages were used to perform all statistical
analyses.
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Results
Semen quality according to different WHO criteria
Using the reference ranges in the WHO manual 4th Edition,
385/905 (42.5%) semen samples were classed as normozoospermic
with the remainder having 1 or more abnormalities as shown in Table
2. However, classification of the same samples using the reference
ranges provided in the WHO manual 5th Edition showed that 697/905
(77.0%) were said to be normozoospermic, simply as a consequence of
lower limits of normality. Table 2 also shows that of the 520 samples
with 1 or more abnormalities according to WHO 4th Edition, 78 (25%)
had the same number when classisfied according to WHO 5th Edition
and 442 (85%) had a reduction in the number of abnormalities.

Semen analysis and DNA fragmentation
A summary of the 905 semen analysis results and their correlation
with the corresponding DNA fragmentation results is shown in Table
3. A significant positive correlation was seen between SDF and sexual
abstinence (ie longer abstinence associated with higher SDF), whereas
significant negative correlations (ie lower semen quality associated
with higher SDF) were seen between SDF and sperm concentration,
motility and morphology.
The mean DNA fragmentation results according to semen quality
are shown in Table 4. The only statistically significant difference in DFLs
between samples classified under the 4th and 5th Editions was for the
normozoospermic samples. However, for both classification systems as
shown in Table 4, there were significant increases in the DFLs as the
severity of semen abnormalities increased.
Semen Parameters

WHO 4th Edition

WHO 5th Edition

Volume (mL)

2

1.5

Sperm Concentration (106/mL)

20

15

Motility

50% (a + b)*

32% (a + b)*

Morphology (% normal)

14

4

*Grade a=rapid progressive motility (>25 µm/s), *Grade b=slow/sluggish
progressive motility (5-25 µm/s).
Table 1: WHO 4th Edition and WHO 5th Edition semen analysis criteria cut off
values. (Adapted from Esteves, et al. [28]).
WHO 5th Edition

Abnormalities

WHO 4th Edition

0

1

2

3

Total

0

385

0

0

0

385

1

233

46

0

0

279

2

72

81

19

0

172

3

7

25

24

13

69

Total

697

152

43

13

905

Table 2: The number of abnormalities (sperm concentration, motility or morphology)
in 905 semen samples when classified according to the reference ranges of WHO
4th and 5th Edition manuals.
Variable

Value

Pearson’s r

P value

Abstinence (days ± SEM)

4.1 ± 0.2

0.11

0.001*

Volume (ml ± SEM)

3.5 ± 0.1

0.05

0.159

Sperm concentration (x106/ml ± SEM)

68.6 ± 2.2

-0.17

0.000*

Sperm motility (% ± SEM)

59.0 ± 0.6

-0.30

0.000*

Sperm morphology (% ± SEM)

14.0 ± 0.2

-0.24

0.000*

Values are presented as mean ± SEM.
*Significant association.
Table 3: Pearson Correlation for DNA fragmentation level to corresponding semen
parameters, 905 samples from 863 men were analysed.
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WHO 4th Edition

Semen Quality

Significance between 4th
and 5th Editions

WHO 5th Edition

n

SDF (%)

n

SDF (%)

p

Oligozoospermia (O)

31

23.3 ± 2.8th

99

27.0 ± 1.7l,o,p

NS

Oligoteratozoospermia (OT)

77

27.6 ± 2.0e,i

18

31.0 ± 4.4

NS

Oligoasthenozoospermia (OA)

10

28.1 ± 6.4

21

33.4 ± 4.3m

NS

Oligoasthenoteratozoospermia (OAT)

69

37.0 ± 2.6d,g,h,i

13

46.6 ± 5.8n,p

NS

Normozoospermic (N)

385

17.5 ± 0.6a,b,c,d,e,j

697

20.3 ± 0.6j,k,l,m,n

0.001
NS

Normoteratozoospermia (NT)

203

21.8 ± 1.2c,f,g

21

29.9 ± 4.9

Normoasthenozoospermia (NA)

45

28.0 ± 3.2a

32

39.4 ± 4.6k,o

NS

Normoasthenoteratozoospermia (NAT)

85

30.7 ± 2.1b,f

4

36.1 ± 9.6

NS

Statistical differences within the same manual edition are represented with the same superscript and are significantly different (p<0.05). NS=Not significant.
Table 4: DNA Fragmentation levels (mean ± SEM) corresponding to semen parameters classified according to different WHO semen analysis editions (n=905).
Semen quality

Abnormal SDF/Total (%)
WHO 4th Edition

WHO 5th Edition

Oligozoospermia (O)

6/31 (19.4%)

31/99 (31.3%)

P value
0.100

Oligoteratozoospermia (OT)

22/77 (28.6%)

7/18 (38.9%)

0.195
0.345

Oligoasthenozoospermia (OA)

4/10 (40.0%)

10/21 (47.6%)

Oligoasthenoteratozoospermia (OAT)

37/69 (53.6%)

10/13 (76.9%)

0.060

Normozoospermic (N)

45/385 (11.7%)

112/697 (16.0%)

0.025*

Normoteratozoospermia (NT)

34/203 (16.8%)

9/21 (42.9%)

0.002*

Normoasthenozoospermia (NA)

13/45 (28.9%)

17/32 (53.1%)

0.016*

Normoasthenoteratozoospermia (NAT)

38/85 (44.7%)

3/4 (75.0%)

0.117

*Significant association.
Table 5: Proportion of samples with abnormal DNA fragmentation levels (>30%) corresponding to WHO 4th Edition and WHO 5th Edition semen analysis criteria.

Samples classified as OAT by the 4th Edition semen analysis criteria
had significantly higher DFLs than O (p<0.01) as did the samples
classified by the 5th Edition (p<0.001). NA samples, classified under
both 4th and 5th Edition criteria had significantly higher DFLs than N
samples (p<0.001 and p<0.0001 respectively).

Discussion

This study has evaluated the relationships between semen quality as
determined using both the WHO 4th and 5th Edition semen analysis
criteria, and DFLs as identified by the Halosperm G2 test kit. The results
reveal significantly higher DFLs in samples that have been classified
as being abnormal compared with those with a semen analysis within
normal parameters regardless of which edition of the WHO guidelines
are used. Oligoasthenoteratozoospermic samples had the highest
DFLs when compared to oligozoospermic, teratozoospermic and
asthenozoospermic samples and it was evident that the proportion of
samples with abnormal DFLs was higher when the WHO 5th Edition
semen analysis criteria were applied compared to the 4th Edition
criteria. No statistical difference was observed however between the
specifically categorised semen defects when the two different guidelines
were applied. Only samples with both abnormal motility and
morphology, as scored using the 4th Edition criteria, showed a mean
abnormal DFL. In contrast, all samples with some abnormality scored
using 5th Edition semen analysis criteria revealed a mean abnormal
DFL. The general finding that there is an inverse relationship between
DFL and sperm morphology and motility, i.e. higher DFL when the
proportion of sperm with normal morphology and motility is reduced,
concurs with other reports [17,24-27].

Semen analysis is intended as a screening test to identify potential
sub-fertility in men. As such, the test must be conducted under standard
conditions so that the results of one man may be compared directly
with others. This includes a standard period of sexual abstinence prior
to production of the sample, as well as the use of standardized analytical
procedures. To this end, the WHO have produced a series of manuals
which include guidelines on the performance of semen analysis, and
a series of reference ranges against which the samples may be judged.
These manuals have undergone periodic revision and the last two
editions, the 4th and 5th, are the ones in most frequent use these days.

Semen samples showed an inverse relationship between sperm
concentration with DFL. This is in accord with Irvine et al., [25] who
used WHO 3rd Edition criteria which has the same sperm concentration
criteria as the 4th Edition [28]. Nevertheless, the proportion of samples
with normal parameters according to the WHO 4th and 5th Editions
but with DFLs >30% were 11.7% and 16% respectively. This is aligned
with others’ findings whereby approximately 15% of infertile men
tested have semen within normal parameters [9,10]. Table 5 shows
that a higher proportion of semen samples with normal sperm
concentrations according to the 5th Edition but abnormalities of sperm

Comparing means of DFL for the various categories of semen
quality is limited in that each group will have a mixture of samples
with normal and clinically abnormal levels of DFL. Table 5 shows
another way of looking at this by considering the proportion of semen
samples that registered an abnormal sperm DFL (>30%) according to
the corresponding semen analysis classification.
Samples recorded with sperm concentration, morphology and
progressive motility levels outside of the WHO 4th and 5th Edition
reference, revealed the highest proportion of samples with abnormal
DFL (>30%), whilst the lowest proportion of samples with abnormal
DFLs were shown to be within normal limits for all concentrations,
morphology and progressive motility regardless of which manual’s
criteria were used.
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morphology and/or motility have significantly elevated DFLs. The
inclusion of a test of sperm DNA fragmentation is therefore important
in providing additional information about the condition of the sperm.
Men producing samples with abnormal DFLs may therefore approach
assisted reproduction with a number of different strategies to help
achieve a pregnancy, including the use of antioxidants [29], ICSI [16]
or frequent ejaculation [30].
In summary, the present study has shown that there is an
association between semen quality and DFL. The measurement of
sperm DNA fragmentation does give further information on which to
base decisions regarding future treatment. Care should also be taken
as the reference range used in interpreting the semen analysis does
influence the prevalence of abnormal DFL.
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